Patents by Inventor Gordon Blunn

Gordon Blunn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11678990
    Abstract: A device for facilitating the formation of new bone tissue includes a body that defines an upper portion and a lower portion, the lower portion having a substantially frustum-like shape, the upper portion having a substantially cylindrical shape. The lower portion is adapted to be inserted into the medullary canal of a bone.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: June 20, 2023
    Assignees: ADLER ORTHO S.P.A., I-ETHOS MEDICAL LTD
    Inventors: Duncan Whitwell, Adrian Taylor, Ben Kendrick, Deborah Higgs, Mark Falworth, Max Gibbons, Tom Cosker, Mike Parry, Jonathan Stevenson, Andy Johnston, Scott Sommerville, Luke Johnson, Richard Boyle, Gordon Blunn, Solomon Dadia, Panos Gikas
  • Patent number: 11413374
    Abstract: There is described a multiphasic osteochondral scaffold for osteochondral defect repair, the scaffold comprising a bone phase and a cartilage phase, wherein the bone phase comprises a support matrix and the cartilage phase comprises a polymeric matrix, and the scaffold comprises a non-porous layer between the bone phase and the cartilage phase. Also described is a multiphasic osteochondral scaffold for osteochondral defect repair, the scaffold comprising a bone phase and a cartilage phase, wherein the bone phase comprises a support matrix and the cartilage phase comprises a polymeric matrix, and wherein the support matrix is tapered so that the dimensions of the support matrix are less at the lower end of the support matrix than at the upper end of the support matrix.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: August 16, 2022
    Assignee: UCL BUSINESS LTD
    Inventors: Chaozong Liu, Gordon Blunn
  • Publication number: 20210228362
    Abstract: A device for facilitating the formation of new bone tissue includes a body that defines an upper portion and a lower portion, the lower portion having a substantially frustum-like shape, the upper portion having a substantially cylindrical shape. The lower portion is adapted to be inserted into the medullary canal of a bone.
    Type: Application
    Filed: June 12, 2019
    Publication date: July 29, 2021
    Inventors: Duncan WHITWELL, Adrian TAYLOR, Ben KENDRICK, Deborah HIGGS, Mark FALWORTH, Max GIBBONS, Tom COSKER, Mike PARRY, Jonathan STEVENSON, Andy JOHNSTON, Scott SOMMERVILLE, Luke JOHNSON, Richard BOYLE, Gordon BLUNN, Solomon DADIA, Panos GIKAS
  • Patent number: 10751201
    Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: August 25, 2020
    Assignee: Stanmore Implants Worldwide Limited
    Inventors: Paul Unwin, Gordon Blunn
  • Publication number: 20190209327
    Abstract: An implant for repairing a segmental defect in a subject's bone at a segmental defect site, the implant comprising a scaffold for implantation at the segmental defect site and the implant optionally comprising: a plate for internal fixation, the plate being attachable to or integral with the scaffold, and the plate having means for securing it to bone outside of the segmental defect site; a hollow cavity within the scaffold; a plurality of longitudinal channels within the scaffold; and or a membrane received around the scaffold.
    Type: Application
    Filed: August 16, 2017
    Publication date: July 11, 2019
    Applicant: FITZBIONICS LIMITED
    Inventors: Noel Fitzpatrick, Jayantilal Meswania, Gordon Blunn
  • Publication number: 20190009004
    Abstract: There is described a multiphasic osteochondral scaffold for osteochondral defect repair, the scaffold comprising a bone phase and a cartilage phase, wherein the bone phase comprises a support matrix and the cartilage phase comprises a polymeric matrix, and the scaffold comprises a non-porous layer between the bone phase and the cartilage phase. Also described is a multiphasic osteochondral scaffold for osteochondral defect repair, the scaffold comprising a bone phase and a cartilage phase, wherein the bone phase comprises a support matrix and the cartilage phase comprises a polymeric matrix, and wherein the support matrix is tapered so that the dimensions of the support matrix are less at the lower end of the support matrix than at the upper end of the support matrix.
    Type: Application
    Filed: January 9, 2017
    Publication date: January 10, 2019
    Applicant: UCL BUSINESS PLC
    Inventors: Chaozong LIU, Gordon BLUNN
  • Patent number: 10117749
    Abstract: A subtalar joint implant (20) is disclosed for replacing a natural subtalar joint existing between the talus (102) and calcaneum (104) bones of a patient. In an embodiment the implant comprises talar (22) and calcaneal (24) portions that are configured to slide over each other in the implanted state. The implant is shaped so that the sliding is constrained to trajectories that involve pivoting of the talar portion relative to the calcaneal portion about a pivot point (36) or a line (38) of pivot points.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: November 6, 2018
    Assignee: UCL Business, LLC
    Inventors: Andy Goldberg, Gordon Blunn
  • Publication number: 20180085238
    Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.
    Type: Application
    Filed: December 1, 2017
    Publication date: March 29, 2018
    Applicant: Stanmore Implants Worldwide Limited
    Inventors: Paul Unwin, Gordon Blunn
  • Patent number: 9855153
    Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: January 2, 2018
    Assignee: Stanmore Implants Worldwide Limited
    Inventors: Paul Unwin, Gordon Blunn
  • Publication number: 20170246004
    Abstract: A subtalar joint implant (20) is disclosed for replacing a natural subtalar joint existing between the talus (102) and calcaneum (104) bones of a patient. In an embodiment the implant comprises talar (22) and calcaneal (24) portions that are configured to slide over each other in the implanted state. The implant is shaped so that the sliding is constrained to trajectories that involve pivoting of the talar portion relative to the calcaneal portion about a pivot point (36) or a line (38) of pivot points.
    Type: Application
    Filed: September 11, 2015
    Publication date: August 31, 2017
    Inventors: Andy Goldberg, Gordon Blunn
  • Publication number: 20170071763
    Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Applicant: Stanmore Implants Worldwide Limited
    Inventors: Paul Unwin, Gordon Blunn
  • Patent number: 9572674
    Abstract: A prosthesis for implantation in an animal or human subject, said prosthesis comprising a first component for attaching to a radius bone in use and a s second component for attaching to an ulna bone in use, the prosthesis further comprising a linkage for linking the first and second components substantially rigidly with respect to one another in use. Preferably the prosthesis is configured to allow the linkage to move relative to the first and/or second components and be retained substantially rigidly at a selected position in normal use, such that the first and second components can be retained substantially rigidly relative to one another in normal use.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: February 21, 2017
    Assignee: Fitzbionics Limited
    Inventors: Noel Fitzpatrick, Gordon Blunn, Jayantilal Mohanlal Meswania
  • Patent number: 9452066
    Abstract: A transcutaneous prosthesis which includes a first component shaped for implantation into a bone, a second component intended for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells, and a third component intended for location exterior to the skin surface having a low surface energy which deters bacterial adhesion.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: September 27, 2016
    Assignee: University College London
    Inventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
  • Publication number: 20140148912
    Abstract: A prosthesis for implantation in an animal or human subject, said prosthesis comprising a first component for attaching to a radius bone in use and a s second component for attaching to an ulna bone in use, the prosthesis further comprising a linage for linking the first and second components substantially rigidly with respect to one another in use. Preferably the prosthesis is configured to allow the linkage to move relative to the first and/or second components and be retained substantially rigidly at a selected position in normal use, such that the first and second components can be retained substantially rigidly relative to one another in normal use.
    Type: Application
    Filed: June 14, 2012
    Publication date: May 29, 2014
    Applicant: FITZBIONICS LIMITED
    Inventors: Noel Fitzpatrick, Gordon Blunn, Jayantilal Mohanlal Meswania
  • Publication number: 20140107806
    Abstract: A transcutaneous prosthesis which includes a first component shaped for implantation into a bone, a second component intended for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells, and a third component intended for location exterior to the skin surface having a low surface energy which deters bacterial adhesion.
    Type: Application
    Filed: December 19, 2013
    Publication date: April 17, 2014
    Applicant: University College London
    Inventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
  • Patent number: 8628584
    Abstract: A transcutaneous prosthesis includes a first component shaped for implantation into a bone, the first component including flutes or grooves on a surface thereof for deterring rotation of the prosthesis within a bone; a second component adapted for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells; and a third component adapted for location to extend from the skin surface and is adapted to extend directly from the skin surface in use, the third component having a coating of a non-stick material on an outer surface thereof, the coating having a surface energy that is lower than a surface energy of the first and second components and which is low enough to deter bacterial adhesion.
    Type: Grant
    Filed: January 3, 2006
    Date of Patent: January 14, 2014
    Assignee: University College London
    Inventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
  • Patent number: 8137409
    Abstract: A method of installing a transcutaneous prosthesis which includes a first component, a second component adapted for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells and a third component adapted for location to extend from the skin surface and the third component having an outer surface. The outer surface of the third component has a surface energy that is lower than a surface energy of at least the first component and which is low enough to deter bacterial adhesion. The method includes attaching the first component to a bone such that a transition from the second component to the third component is essentially at the surface of the skin and the third component extends from the skin surface when the first component is attached to a bone.
    Type: Grant
    Filed: September 13, 2010
    Date of Patent: March 20, 2012
    Assignee: University College London
    Inventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
  • Publication number: 20120035734
    Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.
    Type: Application
    Filed: March 24, 2010
    Publication date: February 9, 2012
    Applicant: STANMORE IMPLANTS WORLDWIDE LIMITED
    Inventors: Paul Unwin, Gordon Blunn
  • Publication number: 20100331996
    Abstract: A method of installing a transcutaneous prosthesis which includes a first component, a second component adapted for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells and a third component adapted for location to extend from the skin surface and the third component having an outer surface. The outer surface of the third component has a surface energy that is lower than a surface energy of at least the first component and which is low enough to deter bacterial adhesion.
    Type: Application
    Filed: September 13, 2010
    Publication date: December 30, 2010
    Applicant: University College London
    Inventors: Gordon Blunn, Justin Cobb, Allen Goodship, Paul Unwin
  • Publication number: 20100249925
    Abstract: A method of surface treatment of at least part of a surface of an implant, said method comprising: electrochemical deposition of a layer containing calcium and phosphorus ions onto a metallic substrate; and incorporation of a therapeutic agent into said electrochemically deposited layer and an implant so treated.
    Type: Application
    Filed: February 8, 2008
    Publication date: September 30, 2010
    Applicant: UCL BUSINESS PLC
    Inventors: Gordon Blunn, Yaser Ghani, Paul Unwin